Fundação de Amparo à Pesquisa do Estado de São Paulo   Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4
Founded: São Paulo Portugal (1962)

Organization Overview

First Clinical Trial
1999
NCT00480870
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundação de Amparo à Pesquisa do Estado de São Paulo

Active Ingredients

Drugs in Phase 4 Trials (61)

acetaminophen (tylenol) (1 trial)

acetylcysteine (mucomyst) (5 trials)

acetylsalicylic acid (aspirin) (2 trials)

articaine (Septocaine) (2 trials)

atenolol (tenormin) (1 trial)

azithromycin (zithromax) (1 trial)

budesonide (rhinocort) (1 trial)

carvedilol (coreg) (1 trial)

chlorhexidine (hibitane) (5 trials)

citalopram (celexa) (1 trial)

clomifene (clomid) (2 trials)

collagen (1 trial)

connective tissue graft (1 trial)

dabigatran (pradaxa) (1 trial)

desogestrel (Mercilon) (1 trial)

donepezil (aricept) (2 trials)

edetic acid (1 trial)

enalapril (vasotec) (1 trial)

enoxaparin (lovenox) (1 trial)

epinephrine (levophed) (2 trials)

esomeprazole (nexium) (2 trials)

estradiol (progynon depot) (2 trials)

fludrocortisone (florinef) (1 trial)

fluoxetine (prozac) (2 trials)

formoterol (foradil) (1 trial)

glucose (2 trials)

glyburide (micronase) (1 trial)

heparin (liquaemin) (1 trial)

house dust mite allergen (1 trial)

hyaluronic acid (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ibuprofen (motrin) (1 trial)

inactivated influenza vaccine (2 trials)

insulin human (humulin) (2 trials)

isoflurane (forane) (3 trials)

ketoprofen (orudis) (1 trial)

leuprolide (lupron) (1 trial)

lidocaine (xylocaine) (3 trials)

losartan (cozaar) (1 trial)

metoprolol (lopressor) (2 trials)

midazolam (versed) (1 trial)

minocycline (minocin) (1 trial)

naproxen (naprosyn) (2 trials)

norgestrel (Ovral) (2 trials)

omeprazole (prilosec) (1 trial)

paroxetine (paxil) (1 trial)

piroxicam (feldene) (1 trial)

polidocanol (asclera) (2 trials)

prednisone (meticorten) (3 trials)

procaine benzylpenicillin (novocaine) (2 trials)

propofol (diprivan) (2 trials)

quetiapine (seroquel) (1 trial)

sertraline (zoloft) (3 trials)

simvastatin (zocor) (1 trial)

sitagliptin (januvia) (3 trials)

sodium citrate (1 trial)

topiramate (topamax) (1 trial)

triamcinolone (kenalog) (4 trials)

tribulus terrestris (1 trial)

urea (2 trials)

warfarin (coumadin) (2 trials)

Drugs in Phase 3 Trials (25)

allopurinol (zyloprim) (1 trial)

amitriptyline (elavil) (1 trial)

amlodipine (norvasc) (2 trials)

antigen pulsed dendritic cells (1 trial)

bevacizumab (avastin) (3 trials)

cannabidiol (Epidiolex) (1 trial)

clarithromycin (biaxin) (1 trial)

doxycycline (vibramycin) (3 trials)

escitalopram (lexapro) (1 trial)

fatty acid (1 trial)

folic acid (1 trial)

furazolidone (furoxone) (1 trial)

ketamine (ketalar) (1 trial)

linseed oil (2 trials)

melatonin (2 trials)

methotrexate (1 trial)

metronidazole (flagyl) (1 trial)

naltrexone (revia) (1 trial)

paraffin oil (1 trial)

polihexanide (1 trial)

ramipril (altace) (1 trial)

sildenafil (viagra) (3 trials)

sodium chloride (2 trials)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 2 Trials (12)

chloroquine (1 trial)

clopidogrel (plavix) (1 trial)

colchicine (colbenemid) (1 trial)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

fish oil (Omegavan) (1 trial)

glutathione (1 trial)

ivabradine (corlanor) (1 trial)

live, attenuated, dengue serotype 1, 2, 3, 4 virus (1 trial)

ozone (1 trial)

paclitaxel (taxol) (1 trial)

ranibizumab (lucentis) (2 trials)

ticagrelor (brilinta) (1 trial)

Drugs in Phase 1 Trials (5)

curcumin (1 trial)

hydrogen peroxide (1 trial)

mepivacaine (carbocaine) (1 trial)

prilocaine (citanest) (1 trial)

ropivacaine (naropin) (2 trials)

Drugs in Other Trials (38)

albuterol (proventil) (1 trial)

amiodarone (cordarone) (1 trial)

auranofin (ridaura) (1 trial)

blueberry (1 trial)

bosentan (tracleer) (1 trial)

bupropion (wellbutrin) (1 trial)

caffeine (1 trial)

ciprofloxacin (cipro) (1 trial)

coffee (1 trial)

cranberry (1 trial)

cyclophosphamide (cytoxan) (1 trial)

dendritic cells (1 trial)

dolutegravir (tivicay) (1 trial)

doxorubicin (Doxil) (1 trial)

estriol (1 trial)

fluorouracil (efudex) (1 trial)

gadoteric acid (Dotarem) (1 trial)

guar gum (1 trial)

hepatitis a vaccine, inactivated (vaqta) (1 trial)

icosapent ethyl (vascepa) (1 trial)

levobupivacaine (chirocaine) (1 trial)

maraviroc (selzentry) (1 trial)

metamizole (Novalgin) (1 trial)

methylene blue (proveblue) (1 trial)

methylprednisolone (medrol) (1 trial)

mycophenolate (CellCept) (1 trial)

olive (1 trial)

oxaliplatin (eloxatin) (1 trial)

pomegranate (1 trial)

sirtuin (1 trial)

soybean (1 trial)

tadalafil (cialis) (1 trial)

taurine (2 trials)

testosterone (delatestryl) (1 trial)

varenicline (chantix) (1 trial)

vasopressin (vasostrict) (1 trial)

whey protein (1 trial)

zinc (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Alcoholism (Phase 3)

Alzheimer Disease (Phase 4)

Angina Pectoris (Phase 3)

Anterior Wall Myocardial Infarction (Phase 3)

Antiphospholipid Syndrome (Phase 4)

Apnea (Phase 4)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 4)

Asthma (Phase 4)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Autoimmune Diseases (Phase 4)

Bacteremia (Phase 4)

Behavior, Addictive (Phase 3)

beta-Thalassemia (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cardiomegaly (Phase 4)

Cardiomyopathies (Phase 3)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 4)

Chagas Disease (Phase 2)

Cognitive Dysfunction (Phase 4)

Collagen Diseases (Phase 4)

Compulsive Personality Disorder (Phase 4)

Connective Tissue Diseases (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Cystinosis (Phase 4)

Dengue (Phase 2)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Depressive Disorder, Treatment-Resistant (Phase 2)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Dermatomyositis (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Nephropathies (Phase 4)

Diabetic Retinopathy (Phase 2)

Disease (Phase 4)

Eczema (Phase 4)

Edema (Phase 3)

Endometriosis (Phase 4)

Fibrosis (Phase 3)

Gastrointestinal Neoplasms (Phase 2)

Gingivitis (Phase 4)

Head and Neck Neoplasms (Phase 2)

Heart Failure (Phase 2)

Helicobacter Infections (Phase 3)

HIV Infections (Phase 2)

Hyperalgesia (Phase 3)

Hypersensitivity (Phase 4)

Hypertension (Phase 4)

Hypertrophy (Phase 4)

Hypogonadism (Phase 2)

Hyponatremia (Phase 2)

Infarction (Phase 4)

Infections (Phase 3)

Influenza, Human (Phase 4)

Iron Overload (Phase 3)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Liver Cirrhosis (Phase 3)

Lupus Erythematosus, Systemic (Phase 4)

Macular Edema (Phase 3)

Migraine Disorders (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 2)

Obesity (Phase 4)

Obsessive-Compulsive Disorder (Phase 4)

Osteoarthritis (Phase 4)

Periodontal Diseases (Phase 3)

Periodontitis (Phase 4)

Pneumonia (Phase 1)

Pneumonia, Ventilator-Associated (Phase 1)

Proteinuria (Phase 4)

Pulpitis (Phase 4)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Raynaud Disease (Phase 3)

Recurrence (Phase 3)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Retinal Diseases (Phase 2)

Rheumatic Diseases (Phase 4)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Limited (Phase 3)

Scleroderma, Localized (Phase 3)

Scleroderma, Systemic (Phase 4)

Sjogren's Syndrome (Phase 4)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Spondylarthritis (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Stroke (Phase 4)

Syndrome (Phase 4)

Systemic Vasculitis (Phase 4)

Telangiectasis (Phase 4)

Thalassemia (Phase 3)

Thinness (Phase 4)

Thrombosis (Phase 4)

Tooth, Impacted (Phase 4)

Toxoplasmosis (Phase 3)

Toxoplasmosis, Ocular (Phase 3)

Varicose Veins (Phase 4)

Vascular Diseases (Phase 4)

Vasculitis (Phase 4)

Ventricular Remodeling (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 125
  • # of Trial APIs: 141